The results of 13 C urea breath tests (UBTs) of 805 dyspeptic patients, and data on the patients' subsequent prescriptions, were gathered from two databases. Overall, 374 patients had a positive ...

Dyspepsia is defined as an epigastric pain or discomfort thought to originate in the upper gastrointestinal (GI) tract. There is discussion, especially in uninvestigated patients, about whether ...

Objective Functional dyspepsia (FD) is a chronic gastroduodenal disorder. Individuals with FD demonstrate visceral hypersensitivity, abnormal central pain processing, and low mood, but it is unclear ...

Acotiamide hydrochloride is under clinical development by Zeria Pharmaceutical and currently in Phase III for Functional (Non Ulcer) Dyspepsia. According to GlobalData, Phase III drugs for Functional ...

Background and Aim: Functional dyspepsia (FD) is a common condition seen in primary gastroenterology practice. The present study was conducted to compare the clinical effectiveness of mosapride ...

Objective To determine the efficacy of acotiamide, an acetylcholinesterase inhibitor, in patients with functional dyspepsia (FD) in a 4-week trial Methods A multicentre, randomised, placebo-controlled ...

Problem: Rising demand and increasing waiting times for upper gastrointestinal endoscopy (gastroscopy). Design: Quality improvement study with pre- and post-intervention data collection. Setting: ...

Describes the nature of a clinical study. Types include: Observational study — observes people and measures outcomes without affecting results. Interventional study (clinical trial) — studies new ...